Near-Infrared Fluorescent Imaging of Cerebral Thrombi and Blood–Brain Barrier Disruption in a Mouse Model of Cerebral Venous Sinus Thrombosis
暂无分享,去创建一个
Ralph Weissleder | Dawid Schellingerhout | R. Weissleder | F. Jaffer | C. Tung | Dong-Eog Kim | D. Schellingerhout | Farouc A Jaffer | Ching-Hsuan Tung | Dong-Eog Kim
[1] R. Weissleder,et al. Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi , 2004, Circulation.
[2] Ralph Weissleder,et al. Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.
[3] J. Ferro,et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) , 2004, Stroke.
[4] O W Witte,et al. Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green. , 2004, Journal of neurology, neurosurgery, and psychiatry.
[5] Ralph Weissleder,et al. Novel Factor XIII Probes for Blood Coagulation Imaging , 2003, Chembiochem : a European journal of chemical biology.
[6] U. Schmidt-Erfurth,et al. Characterization of leakage activity in exudative chorioretinal disease with three-dimensional confocal angiography. , 2003, Ophthalmology.
[7] D. Taggart,et al. Preliminary experience with a novel intraoperative fluorescence imaging technique to evaluate the patency of bypass grafts in total arterial revascularization. , 2003, The Annals of thoracic surgery.
[8] A. Villringer,et al. Beyond the Visible—Imaging the Human Brain with Light , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] R. Weissleder,et al. In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Weissleder,et al. Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.
[11] J. Jarosz,et al. Magnetic resonance imaging of cerebral venous sinus thrombosis. , 2002, Clinical radiology.
[12] V. Fuster,et al. Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque , 2001, Circulation research.
[13] M. Moskowitz,et al. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. , 2001, The American journal of pathology.
[14] G. Cosnard,et al. Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. , 2001, AJNR. American journal of neuroradiology.
[15] I. Bone,et al. Cerebral venous thrombosis: anticoagulants or thrombolyic therapy? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[16] A. Houng,et al. Catalytic Life of Activated Factor XIII in Thrombi: Implications for Fibrinolytic Resistance and Thrombus Aging , 2000, Circulation.
[17] T. Desmettre,et al. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. , 2000, Survey of ophthalmology.
[18] H. Allroggen,et al. Cerebral venous sinus thrombosis , 2000, Postgraduate medical journal.
[19] V. Yee,et al. Blood coagulation factor XIII: structure and function. , 1999, Thrombosis research.
[20] H. Urbach,et al. Diffusion- and perfusion-weighted magnetic resonance imaging in deep cerebral venous thrombosis. , 1999, Stroke.
[21] C. McDougall,et al. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. , 1999, Stroke.
[22] Lewis,et al. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? , 1999, Stroke.
[23] A. Kaufmann,et al. Near-Infrared Spectroscopy Monitored Cerebral Venous Thrombolysis , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[24] M. B. Lewis,et al. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? , 1999, Stroke.
[25] S Mordon,et al. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. , 1998, Microvascular research.
[26] A. D. de Crespigny,et al. Experimental Cerebral Venous Thrombosis: Evaluation Using Magnetic Resonance Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] J. Slakter,et al. Adverse Reactions due to Indocyanine Green , 1994 .
[28] C. S. Davidson,et al. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. , 1960, The Journal of clinical investigation.
[29] E. Wood,et al. A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. , 1957, Proceedings of the staff meetings. Mayo Clinic.